RedOrbitImage Caption: Image of three human mesenchymal stem cells. The ATP in the cells is glowing green. The phosphate from the biomaterial (calcium phosphate) that is taken up by the cells is used to make more ATP, which is traditionally the source of … and more …read more &nbs… Continue reading
EurekAlert (press release)NEW YORK, NY (January 7, 2014) – Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute, working in collaboration with scientists from Columbia University Medical Center (CUMC), for the first time generated induced pluripotent stem …Experimental Vaccine Targets Cancer Stem Cells in Brain TumorsDrug Discovery & DevelopmentPreventing Brain Tumors by Zeroing … Continue reading
Biomaterials get stem cells to commit to a bony futureR & D MagazineImage of three human mesenchymal stem cells. The ATP in the cells is glowing green With the help of biomimetic matrices, a research team led by bioengineers at the Univ. of California, San Diego (UC San Diego) has discovered exactly how calcium … … Continue reading
International Stem Cell Corporation to Present at Biotech Showcase 20144-traders (press release)CARLSBAD, CA–(Marketwired – Jan 7, 2014) – International Stem Cell Corporation ( OTCQB : ISCO ) (www.internationalstemcell.com), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, today … and more …read more &nbs… Continue reading
J&J inks stem cell collaboration with CapricorPharmaTimesUnder the terms of the agreement, J&J’s Janssen unit will help with the development of Capricor’s cell therapy programme for cardiovascular applications, including its lead product, CAP-1002. The latter is an allogeneic adult stem cell therapy derived … …read more &nbs… Continue reading
MICROART : Microart, Inc. Announces Stem Cell Agency Agreement4-traders (press release)HONG KONG , Jan. 7, 2014 (GLOBE NEWSWIRE) — Microart, Inc. (“MCRT” or the “Company”) (OTC:MCRT), a Nevada Corporation , is pleased to announce that it has signed an agency agreement to market stem cell treatments in Germany to its clients in … and more … Continue reading
Future profits ride on battle over stem–cell patentBDliveAS SCIENTISTS get closer to using embryonic stem cells in new treatments for blindness, spinal cord injuries and heart disease, a US legal debate could determine who profits from that research. Consumer Watchdog, a nonprofit advocacy group, wants an … …read more &nbs… Continue reading